Investing.com -- CSPC Pharmaceutical has received approval from the U.S. Food and Drug Administration to conduct clinical trials for its recombinant fully human anti-ActRIIA/IIB monoclonal antibody ...

CSPC Pharmaceutical Group ( ($HK:1093) ) just unveiled an announcement. CSPC Pharmaceutical Group has received marketing approval from China’s ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has shared an announcement. CSPC Pharmaceutical Group announced that its subsidiary, CSPC Innovation ...

[RISK DISCLAIMER] All opinions, news, analysis, prices or other information contained on this report is provided by analyst of Zhejiang Huarui Information Consulting Co., Ltd (CCFGroup) as general ...

However, a new technology called BatteryIQ could make ebike battery fires a thing of the past, thanks to its smart tech with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

In 11 reported incidents, fire caused “three minor burn injuries and property damage totaling over $380,000,” the recall ...

The Hong Kong stock market turned lower again on Thursday, one day after ending the two-day slide in which it had tumbled more than ...

This robust engagement fully reflects the industry’s significant interest in the company’s R&D capabilities and innovation strategy. Professor Li Zhang provided a systematic review of the development ...

The National Finals of the 14th China Innovation and Entrepreneurship Competition Nanotechnology Innovation Professional ...

2018.HK AAC Technologies Holdings Inc.